Guidepoint Global Reaches Two Milestones Tracking the Transcatheter Heart Valve (THV/TCV) Market

Guidepoint Global, LLC, announced the two-year and five-year anniversaries of its U.S. and Outside U.S. Transcatheter Heart Valve (THV/TCV) Market TRACKERS

  • Share on TwitterShare on FacebookShare on Google+Share on LinkedInEmail a friend
With the approval of the Medtronic/CoreValve transcatheter platform, it will be interesting to see how market shares play out both following launch in the short-term but long-term as well.

New York, NY (PRWEB) January 29, 2014

Guidepoint Global, LLC, a leading international primary research firm serving institutional investors and corporations, announced the two-year and five-year anniversaries of its U.S. and Outside U.S. Transcatheter Heart Valve (THV/TCV) Market TRACKERS, respectively. The THV Market TRACKERS deliver monthly web-based access to business and competitive insight such as market share and implant growth by manufacturer and product for Transcatheter Aortic Valve Replacement (TAVR/TAVI), Pulmonary Valve Replacement and Mitral Valve Repair.

Guidepoint’s US and OUS Transcatheter Heart Valve Market TRACKERS aggregate monthly implant data reported by a same-site panel comprised of anonymous respondents who presently represent approximately 18% of the US market demand and 9% of the OUS market demand. Since inception, Guidepoint’s THV market size, market share and other market data (including both quantitative and qualitative perspectives) has provided users with visibility into the market dynamics of valve manufacturers. Volume and growth data from Guidepoint on transfemoral, transapical, and trans-subclavian approaches historically has been highly correlated with product sales figures reported by leading manufacturers. Collectively, the US and OUS THV TRACKERS currently capture data for products manufactured by Edwards Lifesciences, Medtronic, Abbott Laboratories, Boston Scientific, St. Jude Medical, JenaValve Technology, Symetis, and Direct Flow Medical.

In the coming months, THV utilization data provided by US-based implanters will provide a real-world perspective on the effect of evolving market dynamics. “With the approval of the Medtronic/CoreValve transcatheter platform, it will be interesting to see how market shares play out both following launch in the short-term but long-term as well. Guidepoint TRACKER Transcatheter data will provide end users visibility into those dynamics, and more.” said Brian Cosgrove, Director of Guidepoint’s TRACKER Team.

About Guidepoint TRACKER

Guidepoint Global’s TRACKER Solutions are longitudinal studies that equip institutional investors and companies with monthly volume, market share, pricing and additional commercial insight into medical device and biopharmaceutical utilization reported by representative, anonymous, same-site samples.

Guidepoint Global’s TRACKER data and market models are exclusively available to Guidepoint clients via a secure, web-based platform.

Click here for an overview of Guidepoint Global's suite of 27 TRACKER offerings.

About Guidepoint Global, LLC

Guidepoint Global is a leading primary research firm that provides on-demand access to a highly-vetted global network of industry experts. Founded in 2003, Guidepoint covers all sectors, geographies and relevant roles. Sector expertise includes Healthcare, Technology, Media, Telecommunications, Energy, Industrials, Consumer Goods & Services, and Financial Services. Clients include some of the world’s leading private equity firms, multinational corporations, consulting firms and institutional investors.

Guidepoint Global offers primary research services with its network of Advisors via telephone consultations, face-to-face meetings, custom surveys, and proprietary data products. These services, coupled with an industry-leading compliance platform, provide the insight required to make more informed and efficient business decisions.


Contact